Drinking beet juice associated with reduced restenosis after PCI

Published Date: 02 Mar 2023

Dietary nitrate in the form of beet juice reduces restenosis after percutaneous intervention in a randomized trial.

Read Full News

Latest News

Transplant Recipients May Face Higher Endocarditis Mortality

Transplant recipients with infective endocarditis have a distinct microbiological profile and face a significantly higher risk for death at 1 year than non‑transplant control participants.

Medicaid Expansion May Not Curb Severe Maternal Morbidity

Medicaid expansion is linked to an increased proportion of deliveries covered but is not associated with a reduction in severe maternal morbidity during delivery hospitalization.

Certain Social Factors Tied to Metabolic Liver Disease

Food insecurity and neighborhood deprivation were each independently associated with higher incidence of MASLD, with the highest incidence among adults experiencing both.

Sports Unite Doctors in Spain and Beyond

Medical soccer, cycling, and marathon running are helping physicians build camaraderie, stay active, and strengthen professional networks beyond the hospital.

Deep Dive: Two New Drugs, One Disease: MASLD's Three-Specialty Shift

Beyond Gastroenterology: FDA Approvals and Updated Guidelines Shift Frontline MASLD Care to Primary Medicine and Endocrinology

As GLP-1s Revolutionize Obesity Care, Access Remains Uneven

GLP-1 drugs have moved rapidly into the mainstream, but recent data show that many ideal patients are still being left behind.

Todays Updates

Low Awareness of How to Spot Rare Breast Cancer Identified

Researchers survey US adults to assess their knowledge of inflammatory breast cancer.

Remote CBT for Insomnia Improves Symptoms During Chemo

A new randomized trial strengthens the case for managing cancer-related insomnia with cognitive-behavioral therapy.

Long-Acting Interferon Therapy Approved for ET

Ropeginterferon alfa-2b is designed to provide durable disease control.

Todays Updates

Low Awareness of How to Spot Rare Breast Cancer Identified

Researchers survey US adults to assess their knowledge of inflammatory breast cancer.

Remote CBT for Insomnia Improves Symptoms During Chemo

A new randomized trial strengthens the case for managing cancer-related insomnia with cognitive-behavioral therapy.

Long-Acting Interferon Therapy Approved for ET

Ropeginterferon alfa-2b is designed to provide durable disease control.

Latest News

Transplant recipients with infective endocarditis have a distinct microbiological profile and face a significantly higher risk for death at 1 year than non‑transplant control participants.

Medicaid expansion is linked to an increased proportion of deliveries covered but is not associated with a reduction in severe maternal morbidity during delivery hospitalization.

Food insecurity and neighborhood deprivation were each independently associated with higher incidence of MASLD, with the highest incidence among adults experiencing both.

Medical soccer, cycling, and marathon running are helping physicians build camaraderie, stay active, and strengthen professional networks beyond the hospital.

Beyond Gastroenterology: FDA Approvals and Updated Guidelines Shift Frontline MASLD Care to Primary Medicine and Endocrinology

GLP-1 drugs have moved rapidly into the mainstream, but recent data show that many ideal patients are still being left behind.

News All Time

DOACs Benefit AF Patients With Intermediate Stroke Risk

Anticoagulation reduced adverse clinical events in patients with atrial fibrillation at intermediate stroke risk, without an apparent increase in major bleeding.

Heart Failure Drug May Not Improve Exercise Fitness in nHCM

A heart failure drug combination may not improve exercise capacity in patients with nonobstructive hypertrophic cardiomyopathy but is associated with favorable cardiac structural remodeling.

Mounjaro FDA-Approved to Reduce Cardiovascular Risk in T2D

Lilly's Mounjaro (tirzepatide) is now approved to reduce cardiovascular risk in adults with type 2 diabetes.

Weight Down, Steps Down: The GLP-1 Catch

Studies suggest that strong recommendations for exercise with GLP-1s are commonly not heeded; possible reasons vary.

Ginseng, the ‘Miracle Root’: How Strong Is the Evidence?

Evidence varies across ginseng uses, with some potential benefits but limited support for treating fatigue, cognitive decline, infections, diabetes, or cardiovascular disease.

Inpatient Weight Loss May Cut HF Rehospitalization Risk

Losing weight during hospitalization for heart failure in patients treated with intravenous loop diuretics is associated with a reduced 30-day risk for rehospitalization.

Common Lipid-Lowering Drug May Slow Diabetic Eye Damage

A common lipid-lowering drug is tied to markedly lower odds of vision-threatening retinopathy, cataracts, and macular edema in patients with mild or moderate nonproliferative diabetic retinopathy.

What Is Fibermaxxing and Is More Fiber Always Better?

Higher-fiber intake is linked to important health benefits; however, benefits appear to plateau at moderate intake, whereas excessive amounts can cause gastrointestinal symptoms.

Sleep Apnoea Tied to Heart Rhythm Risk in Dialysis Patients

Patients undergoing peritoneal dialysis who have sleep apnoea — particularly those older than 60 years — face an increased risk for new-onset atrial fibrillation, a Finnish study finds.

Diabetes Linked to Higher Risk for Sudden Cardiac Death

Diabetes may independently raise the risk for sudden cardiac death, regardless of obstructive coronary artery disease status.

‘A Lot to Say’: Doctors Use Comics to Deliver Best Medicine

From comics-style stories to New Yorker cartoons, drawing is more than a creative outlet for these doctors — they’ve helped create an impactful new field: graphic medicine.

How to Find the Sweet Spot for Cardio and Strength Training

Many people lean harder on one or the other — or do neither — but more science shows concurrent training may be the key to improved long-term health and vitality.

Overheard in Medicine: Who Owns the Incidental Finding?

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

Gray-Market Retatrutide: Less Weight Loss, More CV Effects

Gray-market retatrutide use is increasing, but unapproved products aren’t delivering expected results. Its manufacturer Eli Lilly is calling for increased oversight.

Professional Corner: AMA Awards $1 Million in Grants

The AHA opens its health tech competition, AMA awards $1 million in community grants, and pediatricians call for stronger protections for children at the US border.

Preclinical Vascular Impairment Tied to Mortality

New criteria identifies preclinical vascular cognitive impairment in adults without dementia or stroke and linked it to higher cardiovascular risk and mortality.

Recommended News For You

FDA Approves Subcutaneous Isatuximab for MM Indications

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

TULSA Is Effective in Long-Term Prostate Cancer Control.

Combination therapy improves outcomes for advanced triple-negative breast cancer

Toxic fungus from King Tutankhamun's tomb yields cancer-fighting compounds—new study

Research indicates that combining AI models enhances the ability to predict breast cancer risk.

Underprescribed for Alcohol Use Disorder is pharmacotherapy.

Recommended Articles For You

Reconstructive Tissue Engineering After Tumor Resection 

An Overview Of Daunorubicin: What Is It Used For And How Does It Work? 

Essential Updates in Hematology in Daily Practice 

Cancer Survivorship and Social Roles: Clinical Implications and Evidence-Based Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

2.

Prostate cancer therapies: AI-based image analysis detects early organ damage

3.

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

4.

OA Tied to Arthritis AE Risk in ICI-Treated Patients

5.

Dr. Prerana S. Nesargi's message for Childhood Cancer Awareness Month 2023 is to increase understanding of pediatric oncology.

1.

The Statistical Paradigm of Leukemia: From Evolving Epidemiology and Molecular Stratification to Precision Therapies and Future Horizons in Leukemia

2.

Hematopoietic Recovery After Childhood Therapy: Mechanisms, Clinical Implications, and Emerging Strategies

3.

Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA

4.

Understanding Verrucous Carcinoma: Symptoms, Diagnosis, and Treatment Options

5.

Genomic Control of Erythropoietic Stem Cell Renewal

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

2.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

3.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

4.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions

5.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot